Harry Schachter
Canadian glycobiologist
Harry Schachter is a renowned Canadian glycobiologist known for his pioneering work in the field of glycobiology, particularly in the study of glycoproteins and glycosylation.
Early life and education[edit | edit source]
Harry Schachter was born in Toronto, Ontario, Canada. He pursued his undergraduate studies at the University of Toronto, where he developed an interest in biochemistry. Schachter continued his education at the same institution, earning a MD degree. His early exposure to the biochemical sciences laid the foundation for his future research in glycobiology.
Career[edit | edit source]
Schachter began his career as a researcher at the Hospital for Sick Children in Toronto, where he focused on the biochemical pathways involved in glycoprotein synthesis. His work led to significant advancements in understanding the role of glycosylation in human health and disease.
Research contributions[edit | edit source]
Schachter's research has been instrumental in elucidating the mechanisms of glycosylation, a critical post-translational modification of proteins. He is particularly noted for his discovery of the N-acetylglucosaminyltransferase enzymes, which play a crucial role in the biosynthesis of N-linked glycoproteins.
His work has provided insights into various genetic disorders related to glycosylation defects, contributing to the development of diagnostic and therapeutic strategies for these conditions. Schachter's research has also explored the implications of glycosylation in cancer and immune system function.
Awards and honors[edit | edit source]
Throughout his career, Schachter has received numerous awards and honors in recognition of his contributions to glycobiology. He is a fellow of the Royal Society of Canada and has been awarded the Order of Canada for his scientific achievements.
Legacy[edit | edit source]
Harry Schachter's work has had a profound impact on the field of glycobiology, influencing both basic research and clinical applications. His discoveries have paved the way for further studies into the role of glycosylation in health and disease, and his legacy continues to inspire new generations of scientists.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
